AAAAAA
Results: 1-25/47
Authors:
GRAVES NM
BRUNDAGE RC
WEN YD
CASCINO G
SO E
AHMAN P
RARICK J
KRAUSE S
LEPPIK IE
Citation: Nm. Graves et al., POPULATION PHARMACOKINETICS OF CARBAMAZEPINE IN ADULTS WITH EPILEPSY, Pharmacotherapy, 18(2), 1998, pp. 273-281
Authors:
LEPPIK IE
Citation: Ie. Leppik, QUALITY-OF-LIFE OF PEOPLE WITH EPILEPSY IN THE UNITED-STATES, Clinical therapeutics, 20, 1998, pp. 13-18
Authors:
KANEKO S
YAGI K
LEPPIK IE
BAKER GA
KUGOH T
Citation: S. Kaneko et al., QUALITY-OF-LIFE EPILEPSY - ROUND-TABLE DISCUSSION, Clinical therapeutics, 20, 1998, pp. 58-60
Authors:
LEPPIK IE
Citation: Ie. Leppik, THE ROLE OF LAMOTRIGINE IN THE TREATMENT OF EPILEPSY, Neurology, 51(4), 1998, pp. 940-942
Authors:
OANA Y
WAND CY
HOSHIKA A
MIYAJIMA T
TAKEI Y
HIRABAYASHI N
KANEKO M
LEPPIK IE
Citation: Y. Oana et al., NEAR-INFRARED SPECTROSCOPY (NIRS) IN TEMPORAL-LOBE EPILEPSY, Neurology, 50(4), 1998, pp. 5071-5071
Authors:
WALCZAK T
HAUSER WA
LEPPIK IE
CASCINO G
RUGGLES K
ANNEGERS JF
RARICK JO
KRAUSE S
Citation: T. Walczak et al., INCIDENCE AND RISK-FACTORS FOR SUDDEN UNEXPECTED DEATH IN EPILEPSY - A PROSPECTIVE COHORT STUDY, Neurology, 50(4), 1998, pp. 12002-12002
Authors:
LEPPIK IE
Citation: Ie. Leppik, ROLE OF NEW AND ESTABLISHED ANTIEPILEPTIC DRUGS, Epilepsia, 39, 1998, pp. 2-6
Authors:
LACKNER TE
CLOYD JC
THOMAS LW
LEPPIK IE
Citation: Te. Lackner et al., ANTIEPILEPTIC DRUG-USE IN NURSING-HOME RESIDENTS - EFFECT OF AGE, GENDER, AND COMEDICATION ON PATTERNS OF USE, Epilepsia, 39(10), 1998, pp. 1083-1087
Authors:
UTHMAN BM
ROWAN AJ
AHMANN PA
LEPPIK IE
SCHACHTER SC
SOMMERVILLE KW
SHU V
Citation: Bm. Uthman et al., TIAGABINE FOR COMPLEX PARTIAL SEIZURES - A RANDOMIZED, ADD-ON, DOSE-RESPONSE TRIAL, Archives of neurology, 55(1), 1998, pp. 56-62
Authors:
RAMSAY RE
WILDER BJ
UTHMAN BM
GARNETT WR
PELLOCK JM
BARKLEY GL
LEPPIK IE
KNAPP LE
Citation: Re. Ramsay et al., INTRAMUSCULAR FOSPHENYTOIN (CEREBYX(R)) IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN, Epilepsy research, 28(3), 1997, pp. 181-187
Authors:
RAMSAY RE
UTHMAN B
LEPPIK IE
PELLOCK JM
WILDER BJ
MORRIS D
CLOYD JC
Citation: Re. Ramsay et al., THE TOLERABILITY AND SAFETY OF VALPROATE SODIUM INJECTION GIVEN AS ANINTRAVENOUS-INFUSION, Journal of epilepsy, 10(4), 1997, pp. 187-193
Authors:
LEPPIK IE
ROTHSCHECTER GB
GRAY GW
COHN MA
OWENS D
Citation: Ie. Leppik et al., DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON OF ZOLPIDEM, TRIAZOLAM, AND TEMAZEPAM IN ELDERLY PATIENTS WITH INSOMNIA, Drug development research, 40(3), 1997, pp. 230-238
Authors:
SACHDEO RC
LEROY RF
KRAUSS GL
DRAKE ME
GREEN PM
LEPPIK IE
SHU VS
RINGHAM GL
SOMMERVILLE KW
Citation: Rc. Sachdeo et al., TIAGABINE THERAPY FOR COMPLEX PARTIAL SEIZURES - A DOSE-FREQUENCY STUDY, Archives of neurology, 54(5), 1997, pp. 595-601
Authors:
LEPPIK IE
Citation: Ie. Leppik, RATIONAL MONOTHERAPY FOR EPILEPSY, Bailliere's clinical neurology, 5(4), 1996, pp. 749-755
Authors:
MURRAY MI
HALPERN MT
LEPPIK IE
Citation: Mi. Murray et al., COST OF REFRACTORY EPILEPSY IN ADULTS IN THE USA, Epilepsy research, 23(2), 1996, pp. 139-148
Authors:
GILNAGEL A
DUBOVSKY J
WILCOX KJ
STEWART JM
ANDERSON VE
LEPPIK IE
ORR HT
JOHNSON EW
WEBER JL
RICH SS
Citation: A. Gilnagel et al., FAMILIAL CEREBRAL CAVERNOUS ANGIOMA - A GENE LOCALIZED TO A 15-CM INTERVAL ON CHROMOSOME 7Q, Annals of neurology, 39(6), 1996, pp. 807-810
Authors:
LEPPIK IE
WOLFF DL
Citation: Ie. Leppik et Dl. Wolff, THE PLACE OF FELBAMATE IN THE TREATMENT OF EPILEPSY, CNS DRUGS, 4(4), 1995, pp. 294-301
Authors:
SO EL
WOLFF D
GRAVES NM
LEPPIK IE
CASCINO GD
PIXTON GC
GUSTAVSON LE
Citation: El. So et al., PHARMACOKINETICS OF TIAGABINE AS ADD-ON THERAPY IN PATIENTS TAKING ENZYME-INDUCING ANTIEPILEPSY DRUGS, Epilepsy research, 22(3), 1995, pp. 221-226
Authors:
GILNAGEL A
WILCOX KJ
STEWART JM
ANDERSON VE
LEPPIK IE
RICH SS
Citation: A. Gilnagel et al., FAMILIAL CEREBRAL CAVERNOUS ANGIOMA - CLINICAL ANALYSIS OF A FAMILY AND PHENOTYPIC CLASSIFICATION, Epilepsy research, 21(1), 1995, pp. 27-36
Authors:
SCHACHTER SC
LEPPIK IE
MATSUO F
MESSENHEIMER J
FAUGHT E
MOORE EL
RISNER ME
Citation: Sc. Schachter et al., LAMOTRIGINE - A 6-MONTH, PLACEBO-CONTROLLED, SAFETY AND TOLERANCE STUDY, Journal of epilepsy, 8(3), 1995, pp. 201-209
Authors:
RAMSAY RE
BARKLEY GL
GARNETT WR
PELLOCK JM
LEPPIK IE
WILDER BJ
UTHMAN B
Citation: Re. Ramsay et al., SAFETY AND TOLERANCE OF INTRAMUSCULAR FOSPHENYTOIN (CEREBYX(R)) IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN, Neurology, 45(4), 1995, pp. 249-249
Authors:
KERRICK JM
KELLEY BJ
MAISTER BH
GRAVES NM
LEPPIK IE
Citation: Jm. Kerrick et al., INVOLUNTARY MOVEMENT-DISORDERS ASSOCIATED WITH FELBAMATE, Neurology, 45(1), 1995, pp. 185-187
Authors:
LEPPIK IE
Citation: Ie. Leppik, THE ART OF EPILEPSY CARE - INTRODUCTION, Epilepsia, 36, 1995, pp. 1-1
Authors:
LEPPIK IE
Citation: Ie. Leppik, TIAGABINE - THE SAFETY LANDSCAPE, Epilepsia, 36, 1995, pp. 10-13
Authors:
LEPPIK IE
GRAM L
BRODIE MJ
BENMENACHEM E
SCHACHTER SC
Citation: Ie. Leppik et al., TIAGABINE - THE ART OF EPILEPSY CARE - A SATELLITE SYMPOSIUM TO THE 21ST INTERNATIONAL-EPILEPSY-CONGRESS, SYDNEY, AUSTRALIA, SEPTEMBER 2, 1995 - DISCUSSION, Epilepsia, 36, 1995, pp. 25-25